Shanghai Bio-heart Biological Technology Co., Ltd.
2185.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$307.59M
Close$
$2.17
66.7% upside
Current Fair Value
66.7% upsideUndervalued by 66.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $307.59 Million |
|---|---|
| Enterprise Value | $396.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.28 |
| Beta | 0.09 |
| Outstanding Shares | 243,417,000 |
Return
| Return on Equity | -40.70% |
|---|---|
| Return on Assets | -20.70% |
| Return on Invested Capital | -18.06% |
Valuation & Multiples
| P/E Ratio | -3.58 |
|---|---|
| PEG | -19.52 |
| Price to Sales | - |
| Price to Book Ratio | 0.65 |
| Enterprise Value to Revenue | 6.75 |
| Enterprise Value to EBIT | -2.83 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 0.45 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
March 26, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shanghai Bio-heart Biological Technology Co., Ltd.
63 employees
CEO: Li Wang Based in the People's Republic of China, Shanghai Bio-heart Biological Technology Co., Ltd. is a medical technology firm specializing in interventional cardiovascular devices. Its core business revolves around delivering bioresorbable sc...